A second human study—Acute Stroke Therapy by Inhibition of Neutrophils (ASTIN)—instead investigated the effect of Mac-1 inhibitor, UK-279,276 (neutrophil inhibitor factor), in AIS patients (Krams et al., 2003). Here, ITGB2 is linked to stroke disorder.